Literature DB >> 10443650

Progressive decline in insulin levels in Rabson-Mendenhall syndrome.

N Longo1, Y Wang, M Pasquali.   

Abstract

Mutations in the insulin receptor gene cause the severe insulin-resistant syndromes leprechaunism and Rabson-Mendenhall syndrome, whose metabolic features include fasting hypoglycemia, post-prandial hyperglycemia, and extremely elevated insulin levels. Patients with Rabson-Mendenhall syndrome have a protracted course and eventually develop ketoacidosis. To determine the mechanism causing this progression and the paradoxical fasting hypoglycemia, we conducted a retrospective study in a patient with Rabson-Mendenhall syndrome, who was a compound heterozygous for two missense mutations affecting the kinase domain of the insulin receptor beta-subunit (I1115T and R1131W). At birth, the patient had fasting hypoglycemia and postprandial hyperglycemia. This was followed at approximately 3 yr of age by constant hyperglycemia and, at 6 yr of age, by constant ketoacidosis. Urinary organic acids during ketoacidosis resembled those of patients with type 1 diabetes. Plasma glucose levels increased (r2 = 0.31; P < 0.01), whereas insulin levels decreased with age (r2 = 0.51; P < 0.01). During periods ofhypoglycemia and hyperglycemia (0-1 yr of age), constant hyperglycemia (3-4 yr of age), and hyperglycemia with ketoacidosis (6-7 yr of age), insulin levels were significantly correlated with plasma glucose levels (P < 0.05). However, the slope of the regression and the predicted insulin level at zero glucose decreased with increasing age. When insulin levels were normalized for the plasma glucose concentrations, an exponential decrease in the insulin/glucose ratio was observed (r2 = 0.92; P < 0.01), with most of the decline occurring before 2 yr of age. These results indicate that the paradoxical fasting hypoglycemia of patients with Rabson-Mendenhall syndrome is associated with severely increased levels of circulating insulin and that the progression of this disease is due to a decline in insulin levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10443650     DOI: 10.1210/jcem.84.8.5902

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Selfness-nonselfness in designing an anti-B19 erythrovirus vaccine.

Authors:  Candida Fasano; Darja Kanduc
Journal:  Self Nonself       Date:  2011-04-01

2.  Decreased half-life of insulin-like growth factor I in Rabson-Mendenhall syndrome.

Authors:  N Longo; R Singh; L J Elsas
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

Review 3.  Metabolic Communication and Healthy Aging: Where Should We Focus Our Energy?

Authors:  Hannah J Smith; Arpit Sharma; William B Mair
Journal:  Dev Cell       Date:  2020-07-02       Impact factor: 12.270

4.  Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice.

Authors:  Haruka Okamoto; Katie Cavino; Erqian Na; Elizabeth Krumm; Sun Y Kim; Xiping Cheng; Andrew J Murphy; George D Yancopoulos; Jesper Gromada
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-23       Impact factor: 11.205

Review 5.  Molecular genetics of pineal region neoplasms.

Authors:  M D Taylor; T G Mainprize; J A Squire; J T Rutka
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

6.  Metreleptin improves blood glucose in patients with insulin receptor mutations.

Authors:  Rebecca J Brown; Elaine Cochran; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2013-08-22       Impact factor: 5.958

7.  The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.

Authors:  Stanley S Schwartz; Solomon Epstein; Barbara E Corkey; Struan F A Grant; James R Gavin; Richard B Aguilar
Journal:  Diabetes Care       Date:  2016-02       Impact factor: 19.112

8.  Successful rhIGF1 treatment for over 5 years in a patient with severe insulin resistance due to homozygous insulin receptor mutation.

Authors:  D Carmody; S S Ladsaria; R K Buikema; R K Semple; S A W Greeley
Journal:  Diabet Med       Date:  2016-03       Impact factor: 4.359

9.  Two Novel Variants and One Previously Reported Variant in the Insulin Receptor Gene in Two Cases with Severe Insulin Resistance Syndrome.

Authors:  Aydilek Dagdeviren Cakir; Said Saidov; Hande Turan; Serdar Ceylaner; Yavuz Özer; Tufan Kutlu; Oya Ercan; Olcay Evliyaoglu
Journal:  Mol Syndromol       Date:  2020-03-18

10.  Rabson-Mendenhall syndrome: medullary sponge kidney, a new component.

Authors:  Andrew M Harris; Bryan Hall; Vesna M Kriss; John L Fowlkes; Stefan G Kiessling
Journal:  Pediatr Nephrol       Date:  2007-09-12       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.